CEimpact Podcast

Join Ashlee as she talks with Bernadette Jakeman, an ID-HIV specialized prescribing pharmacist and associate professor at the University of New Mexico College of Pharmacy. Her expertise lies in infectious diseases and HIV, a field that she's deeply passionate about and has dedicated her career to.

Listen in as she takes us on a fascinating journey, recounting her unique trajectory in the field of pharmacy, her experiences with an HIV specialist in an outpatient setting, and the incredibly impactful work she is currently doing within the HIV community.

In this episode, the two discuss:
- Bernadette's unique pharmacy career path
- Bernadette's work within the HIV community
- How pharmacists play a role in HIV prevention
- The updated Pre-Exposure Prophylaxis guidelines

 For those keen on learning more or who work in the field, Bernadette has prepared an insightful course titled "Preparing for Tomorrow: A Pharmacist Guide to HIV Prevention". So, gear up to learn, engage, and feel empowered to discuss PrEP with patients and advocate for those who need it.

To learn more about CEimpact's By Design memberships and to gain access to Bernadette's course, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Polymyalgia rheumatica is a common rheumatic disorder. Steroids are the mainstay of therapy despite significant adverse reactions. Join host, Geoff Wall, as he evaluates a new treatment for PMR.

The GameChanger
Sarilumab is now FDA-approved for relapsing polymyalgia rheumatica. Sarilumab can be an alternative to long-term steroid therapy or methotrexate.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. PMID: 37792612.

https://www.nejm.org/doi/full/10.1056/NEJMoa2303452

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the diagnosis and treatment of polymyalgia rheumatica
2. Assess the SAPHYR study and the role of sarilumab for treatment of polymyalgia rheumatica

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-352-H01-P
Initial release date: 11/6/2023
Expiration date: 11/6/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Join Ashlee and Tim Ulbrich, pharmacist and founder of Your Financial Pharmacist, in this week's Level Up episode as they discuss Tim's career, advice, and resources that pharmacists can use in the journey toward attaining financial wellness.

Tim Ulbrich, pharmacist & CEO of Your Financial Pharmacist, set out to help pharmacists solve this issue by helping them develop financial planning and organization skills

In this episode, the two discuss:
- How Tim's blog developed into the Your Financial Pharmacist company
- Tim's best tips for pharmacists hoping to work towards financial wellness
- The upcoming CEimpact By Design course 'Dollars and Sense: Guidance for Building a Strong Financial Foundation', a course that Tim helped create.

To learn more about CEimpact's By Design memberships and to gain access to Tim's course, click here.

To get in touch with Your Financial Pharmacist, click here. 

Follow CEimpact on Social Media:
LinkedIn
Instagram

There are numerous formulations of aspirin available over-the-counter often advertised to decrease gastric issues. Join host, Geoff Wall, as he evaluates a new study to see if enteric aspirin is worth the extra money and effort.
 
The GameChanger
Buffered and coated aspirin are purported to cause fewer gastric adverse events. However, no efficacy or safety differences exist in the various formulations of aspirin.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
Sleem A, Effron MB, Stebbins A, et al. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. Published online October 04, 2023. doi:10.1001/jamacardio.2023.3364

https://jamanetwork.com/journals/jamacardiology/fullarticle/2809795?resultClick=1
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the history of various formulations of aspirin on the US market
2. Discuss the results and limitations of the ADAPTABLE study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-331-H01-P
Initial release date: 10/30/2023
Expiration date: 10/30/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Ever imagine what it's like to evolve from a retail pharmacy worker to a celebrated pharmacy technician trainer?

Join Ashlee as she talks with Nicole Foster, the manager of pharmacy technician and client education at CEimpact about her inspiring journey.

During this episode, the two discuss
- Nicole's career and mentors
- The essential shift in the perceptions surrounding pharmacy technicians
- Nicole's predictions about the future of pharmacy technicians

To learn more about our Pharmacist by Design membership, click here. 

Follow CEimpact on Social Media:
LinkedIn
Instagram

Hypertensive urgency - asymptomatic patients with elevated blood pressure - is frequently treated in the hospital and outpatient setting. Join host, Geoff Wall, as he critically examines the evidence to assess risk over benefit.
 
The GameChanger
Treatment of asymptomatic hypertension has not been shown to improve clinical outcomes. Recent data highlights the risk with increased mortality through aggressive management.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
Anderson TS, Herzig SJ, Jing B, et al. Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults. JAMA Intern Med. 2023;183(7):715–723. doi:10.1001/jamainternmed.2023.1667

https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2805021

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the difference between hypertensive urgency and emergency
2. Discuss recent data about the possible harms of treating asymptomatic hypertension in the hospital setting

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-330-H01-P
Initial release date: 10/23/2023
Expiration date: 10/23/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Ever wonder about the journeys behind the professionals working to advance in the pharmacy technician field?

Join Ashlee as she talks with Liza Chapman, the Chief Professional Officer at the PTCB (Pharmacy Technician Certification Board), and Zachary Hall, the Associate Director of Professional Affairs about professional evolution in the pharmacy technician world.

During this episode, the three discuss:
- Liza & Zachary's professional journeys
- The PTCB's work in progressing the pharmacy technician profession
- The relationship between PTCB and P-TEC (Pharmacy Technician Educators Council)
- The relationship between PTCB and CEimpact!

To learn more about our Pharmacist by Design membership, click here. 

Follow CEimpact on Social Media:
LinkedIn
Instagram

Think journal clubs are a heavy lift? That they can't be done in a small pharmacy environment? Worried that you don't have enough statistical savvy? Listen to this episode and you'll discover how journal clubs can be incorporated into just about any setting with some simple strategies. The value they bring is immense - NAPLEX preparation for graduating students, expanded clinical knowledge for the learner and staff, the development of confidence and communication skills in your students and residents, and much more.

In this episode, I talked with Dr. Valerie Coppenrath, a drug information guru and preceptor for both residents and students. She shares some background on the concept, and also provides us with some practical strategies for taking a more intentional approach to supporting our students and residents in their own professional identity journey. And who knows, maybe we’ll learn a little about ourselves along the way as well.

Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Valerie Coppenrath, PharmD
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning Objectives
At the end of this course, preceptors will be able to:
1. Discuss the advantages and challenges with conducting a journal club in a range of pharmacy settings.
2. List strategies for effective journal club selection.
3. Describe strategies for overcoming barriers associated with setting up a successful journal club.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-362-H99-P
Initial release date: 10/18/2026
Expiration date: 10/18/2029
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Injectable, long-acting therapy is a new frontier for hypertension management. Join host, Geoff Wall, as he evaluates zilebesiran, a hepatic angiotensinogen blocker for blood pressure control for up to six months.
 
The GameChanger
Zilebesiran blocks the final production of angiotensinogen at the hepatic level making it safer from a renal perspective than the ACEis or ARBs. A single subcutaneous injection provides therapy for up to six months.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
Desai AS, Webb DJ, Taubel J, et al. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. N Engl J Med. 2023 Jul 20;389(3):228-238. doi: 10.1056/NEJMoa2208391. PMID: 37467498.
https://www.nejm.org/doi/full/10.1056/NEJMoa2208391

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the mechanism of action of Zilebesiran
2. Discuss possible advantages and disadvantages of this drug in the treatment of hypertension

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-323-H01-P
Initial release date: 10/16 /2023
Expiration date: 10/16/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

In the competitive pharmacy world, defining and separating yourself in the profession are keys to success. Far too often we overlook the benefits that can come from establishing a personal brand in this profession - at first glance, it can be a daunting and unfamiliar task.

Join Jen Moulton, President of CEimpact, as she interviews Ashlee, VP of market strategy and the Founder and Executive Career Coach of RX Ashlee, about the process of defining oneself in their profession and how even the slightest changes in how we brand ourselves can have massive benefits on our careers. 

During this episode, the two discuss:
     - Ashlee's experience in personal branding & career coaching
     - The keys to establishing an effective personal brand
     - How these keys can translate into career advancement opportunities 

To access Ashlee's course through our Pharmacist by Design membership, click here. 

Follow CEimpact on Social Media:
LinkedIn
Instagram